ARCA biopharma Announces Resignation from Board of Directors

  ARCA biopharma Announces Resignation from Board of Directors

Business Wire

WESTMINSTER, Colo. -- November 21, 2013

ARCA biopharma, Inc. (Nasdaq: ABIO), today announced that John L. Zabriskie,
Ph.D., has resigned from the Company’s Board of Directors.

Dr. Zabriskie resigned effective November 19, 2013. There has been no
disagreement between the Company and Dr. Zabriskie. Dr. Zabriskie has served
as a member of ARCA’s board of directors since March 2005.

“I want to express our deep gratitude and appreciation for John’s
contributions to ARCA and the Board,” commented Michael Bristow, M.D., Ph.D.,
President and CEO of ARCA. “John has been a tremendous asset, sharing his
extensive experience and wisdom from a highly successful career in our
industry. We will miss his sage advice and steady hand in guiding the
Company.”

Dr. Zabriskie is Co-Founder and Director of Puretech Ventures, LLC, and the
past Chairman of the Board, Chief Executive Officer and President of NEN Life
Science Products, Inc., a supplier of kits for labeling and detection of DNA.
Prior to joining NEN Life Science Products in July 1997, Dr. Zabriskie was
President and Chief Executive Officer of Pharmacia and Upjohn Inc. Prior to
joining Upjohn in 1994, Dr. Zabriskie was Executive Vice President for Merck &
Co., Inc. Dr. Zabriskie received his undergraduate degree in chemistry from
Dartmouth College and his Ph.D. in organic chemistry from the University of
Rochester.

Contact:

ARCA biopharma, Inc.
Investor & Media Contact:
Derek Cole, 720-940-2163
derek.cole@arcabiopharma.com
 
Press spacebar to pause and continue. Press esc to stop.